Javascript must be enabled to continue!
AATF Inhibition Exerts Antiangiogenic Effects Against Human Hepatocellular Carcinoma
View through CrossRef
ABSTRACT
Hepatocellular carcinoma (HCC), a highly fatal cancer with a mortality rate proportional to its incidence, continues to pose a global health care challenge. Angiogenesis is a key factor in the growth and metastasis of hepatic tumors and thus a potential therapeutic target in HCC. We previously showed that the apoptosis antagonizing transcription factor (AATF) affects tumor growth and metastasis in a mouse xenograft model. However, the regulatory role of AATF in tumor angiogenesis and its underlying mechanisms in HCC remain unknown. In the current study, we identified high levels of AATF in human HCC tissues compared to adjacent normal liver tissues, and the expression was found to be correlated with the stages and tumor grades of HCC. Inhibition of AATF in human HCC cells showed high levels of pigment epithelium-derived factor (PEDF) compared to controls as a resultant of reduced matric metalloproteinases activity. Conditioned media from AATF knockdown (KD) cells inhibited the proliferation, migration, and invasion of human umbilical vein endothelial cells as well as the vascularization of the chick chorioallantoic membrane. Furthermore, the VEGF-mediated downstream signaling pathway responsible for endothelial cell survival and vascular permeability, cell proliferation, and migration favoring angiogenesis was suppressed by AATF inhibition. Of note, PEDF inhibition by its respective antibody profoundly reversed the anti-angiogenic effect of AATF KD. In conclusion, our study demonstrates that inhibition of AATF suppresses angiogenesis in HCC via PEDF. Thus, a therapeutic strategy based on the inhibition of AATF to disrupt tumor angiogenesis may be a promising approach for HCC treatment.
Title: AATF Inhibition Exerts Antiangiogenic Effects Against Human Hepatocellular Carcinoma
Description:
ABSTRACT
Hepatocellular carcinoma (HCC), a highly fatal cancer with a mortality rate proportional to its incidence, continues to pose a global health care challenge.
Angiogenesis is a key factor in the growth and metastasis of hepatic tumors and thus a potential therapeutic target in HCC.
We previously showed that the apoptosis antagonizing transcription factor (AATF) affects tumor growth and metastasis in a mouse xenograft model.
However, the regulatory role of AATF in tumor angiogenesis and its underlying mechanisms in HCC remain unknown.
In the current study, we identified high levels of AATF in human HCC tissues compared to adjacent normal liver tissues, and the expression was found to be correlated with the stages and tumor grades of HCC.
Inhibition of AATF in human HCC cells showed high levels of pigment epithelium-derived factor (PEDF) compared to controls as a resultant of reduced matric metalloproteinases activity.
Conditioned media from AATF knockdown (KD) cells inhibited the proliferation, migration, and invasion of human umbilical vein endothelial cells as well as the vascularization of the chick chorioallantoic membrane.
Furthermore, the VEGF-mediated downstream signaling pathway responsible for endothelial cell survival and vascular permeability, cell proliferation, and migration favoring angiogenesis was suppressed by AATF inhibition.
Of note, PEDF inhibition by its respective antibody profoundly reversed the anti-angiogenic effect of AATF KD.
In conclusion, our study demonstrates that inhibition of AATF suppresses angiogenesis in HCC via PEDF.
Thus, a therapeutic strategy based on the inhibition of AATF to disrupt tumor angiogenesis may be a promising approach for HCC treatment.
Related Results
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
AATF inhibition exerts antiangiogenic effects against human hepatocellular carcinoma
AATF inhibition exerts antiangiogenic effects against human hepatocellular carcinoma
Background and aims
Angiogenesis is a key factor in the growth and metastasis of hepatic tumors and thus a potential therapeutic target in hepatocellular carcin...
TACE inhibition: a promising therapeutic intervention against AATF‐mediated steatohepatitis to hepatocarcinogenesis
TACE inhibition: a promising therapeutic intervention against AATF‐mediated steatohepatitis to hepatocarcinogenesis
Metabolic dysfunction‐associated steatohepatitis‐driven hepatocellular carcinoma (MASH‐HCC) is a global clinical challenge for which there is a limited understanding of disease pat...
AATF Inhibition Exerts Antiangiogenic Effects Against Human Hepatocellular Carcinoma
AATF Inhibition Exerts Antiangiogenic Effects Against Human Hepatocellular Carcinoma
Abstract
Hepatocellular carcinoma (HCC), a highly fatal cancer with a mortality rate proportional to its incidence, continues to pose a global health care challenge. Angiog...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Apoptosis Antagonizing Transcription Factor Plays a Dual Role in Remote Preconditioning-Induced Neuroprotection Against Cerebral Ischemia/Reperfusion Injury in Aged Rats
Apoptosis Antagonizing Transcription Factor Plays a Dual Role in Remote Preconditioning-Induced Neuroprotection Against Cerebral Ischemia/Reperfusion Injury in Aged Rats
Abstract
The elderly population is increasingly susceptible to cerebral ischemia/reperfusion (I/R) injury. Although the potential protective effects of remote preconditioni...
Targeting AATF reprograms the tumor microenvironment and suppresses hepatocellular carcinoma via MIR100HG–TGF-β signaling
Targeting AATF reprograms the tumor microenvironment and suppresses hepatocellular carcinoma via MIR100HG–TGF-β signaling
Abstract
Hepatocellular carcinoma (HCC), a leading cause of cancer death, has a dynamic and heterogeneous tumor microenvironment (TME) that drives progression and t...
Evaluating the GALAD Score in Diagnosing Hepatocellular Carcinoma
Evaluating the GALAD Score in Diagnosing Hepatocellular Carcinoma
This paper aims to evaluate the GALAD score in diagnosing hepatocellular carcinoma. The paper conducted a retrospective study of 86 Hepatocellular Carcinoma patients who underwent ...

